BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6112033)

  • 1. The action of polymyxin B at the frog neuromuscular junction.
    Durant NN; Lambert JJ
    Br J Pharmacol; 1981 Jan; 72(1):41-7. PubMed ID: 6112033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular block produced by polymyxin B: interaction with end-plate channels.
    Fiekers JF
    Eur J Pharmacol; 1981 Mar; 70(1):77-81. PubMed ID: 6260516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 4-aminopyridine on the postsynaptic action of polymyxin B.
    Brazil OV; Fontana MD; Pavani NJ
    Eur J Pharmacol; 1989 Jan; 159(1):47-51. PubMed ID: 2540012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and postjunctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics.
    Singh YN; Marshall IG; Harvey AL
    Br J Anaesth; 1982 Dec; 54(12):1295-306. PubMed ID: 6293521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated ionic channel.
    Lambert JJ; Volle RL; Henderson EG
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):5003-7. PubMed ID: 6254051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS; Lambert JJ; Marshall IG
    Br J Pharmacol; 1979 Jan; 65(1):53-62. PubMed ID: 216450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of emetine and dehydroemetine at the frog neuromuscular junction.
    Alkadhi KA
    Eur J Pharmacol; 1987 Jun; 138(2):257-64. PubMed ID: 2887439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of neuromuscular blocking effects of neomycin and polymyxin B.
    Lee C; de Silva AJ
    Anesthesiology; 1979 Mar; 50(3):218-20. PubMed ID: 219730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI
    Can J Physiol Pharmacol; 1987 May; 65(5):747-52. PubMed ID: 2887267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of quantal releases during end-plate currents at the frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1988 Aug; 402():605-26. PubMed ID: 2853224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine effects upon the spontaneous quantal transmitter release at the frog neuromuscular junction in the presence of protein kinase C-blocking and -activating agents.
    Brănişteanu DD; Brănişteanu DD; Covic A; Brailoiu E; Serban DN; Haulica ID
    Neurosci Lett; 1989 Mar; 98(1):96-100. PubMed ID: 2540461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endplate blocking actions of lophotoxin.
    Atchison WD; Narahashi T; Vogel SM
    Br J Pharmacol; 1984 Jul; 82(3):667-72. PubMed ID: 6146369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular and cardiovascular depression produced by prolonged exposure to Polymyxin B.
    de Silva AJ; Lee C
    Can Anaesth Soc J; 1978 Jul; 25(4):303-6. PubMed ID: 208722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the ionophore X-537A on acetylcholine release at the frog neuromuscular junction.
    Kita H; Van Der Kloot W
    J Physiol; 1976 Jul; 259(1):177-98. PubMed ID: 182959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of verapamil at the neuromuscular junction.
    Ribera AB; Nastuk WL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 93(1):137-41. PubMed ID: 2567223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.
    Ribeiro JA; Sebastião AM
    J Physiol; 1987 Mar; 384():571-85. PubMed ID: 2821240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of polymyxin B-induced neuromuscular and cardiovascular depression by 4-aminopyridine in the anesthetized cat.
    Lee C; de Silva AJ; Katz RL
    Anesthesiology; 1978 Oct; 49(4):256-9. PubMed ID: 211879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.